These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5067927)

  • 21. [New compounds and reactions of sulfonamides with amines. XVI. Preparation and study of hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-N'[(1-pyrazolyl) -alkyl] urea].
    Brzozowski Z; Pac-Pomarnacka E; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(4):461-7. PubMed ID: 970168
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparation and antidiabetic activity of new 3-methyl-5-phenylpyrazolesulfonylurea derivatives.
    Soliman R; Feid-Allah HM
    J Pharm Sci; 1981 Jun; 70(6):602-5. PubMed ID: 6788934
    [No Abstract]   [Full Text] [Related]  

  • 23. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential antidiabetic agents. Pyrazolo(3,4-b)pyridines.
    Höhn H; Polacek I; Schulze E
    J Med Chem; 1973 Dec; 16(12):1340-6. PubMed ID: 4358224
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolism of glibornuride in the human].
    Bigler F; Quitt P; Vecchi M; Vetter W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2191. PubMed ID: 4679249
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmacology and metabolism of oral antidiabetic drugs.
    Bänder A
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
    Sarges R; Kuhla DE; Wiedermann HE; Mayhew DA
    J Med Chem; 1976 May; 19(5):695-709. PubMed ID: 1271411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological properties of 1,2-benzisothiazole compounds. Hypoglycemic activity of some benzisothiazolylacylamidoethylbenzensulfonylureas].
    Amoretti L; Agosti A; Catellani PL
    Boll Soc Ital Biol Sper; 1971 May; 47(10):299-302. PubMed ID: 4999859
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].
    Vailati G; Montini M; Pagani G; Caputo G
    Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral hypoglycemic agents: 1-(2-carboxyphenyl)pyrroles.
    Sugihara H; Matsumoto N; Hamuro Y; Kawamatsu Y
    Arzneimittelforschung; 1974 Oct; 24(10):1560-3. PubMed ID: 4479763
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycaemic activity and structure activity relationship of a new series of sulphonylurea derivatives.
    Gandhi TP; Jindal MN
    Arzneimittelforschung; 1971 Jul; 21(7):968-71. PubMed ID: 5109511
    [No Abstract]   [Full Text] [Related]  

  • 34. The quest for a latent action insulin.
    Bradbury AF; Ko AS; Massey DE; Salokangas A; Smyth DG; Sabey GA; Webb FW; Stewart GA
    Postgrad Med J; 1973 Dec; 49():Suppl 7:945-8. PubMed ID: 4772465
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relationship between structure and hypoglycemic activity in a series of amide substituted p-N-R-sulfamidooxanilic acids].
    Chernykh VP; Bannyĭ IP; Valiashko NN; Petiunin PA; Desenko VF
    Farmakol Toksikol; 1979; 42(1):51-5. PubMed ID: 421892
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acylaminoalkylbenzolsulfonylureas].
    Weber H; Aumüller W; Muth K; Weyer R; Heerdt R; Fauland E; Bänder A; Pfaff W; Schmidt FH; Stork H
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1326-46. PubMed ID: 5394451
    [No Abstract]   [Full Text] [Related]  

  • 37. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
    Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML
    J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
    Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V
    Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
    Giannessi F; Pessotto P; Tassoni E; Chiodi P; Conti R; De Angelis F; Dell'Uomo N; Catini R; Deias R; Tinti MO; Carminati P; Arduini A
    J Med Chem; 2003 Jan; 46(2):303-9. PubMed ID: 12519067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.